Aethlon Medical (STU:EJU) Float Percentage Of Total Shares Outstanding: 99.13% (As of Aug. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:EJU Aethlon Medical Inc STU:EJU
19 GF Score
Price €212.00
! 1 Warning Sign
View Full Analysis

What is Aethlon Medical Float Percentage Of Total Shares Outstanding?

Aethlon Medical STU:EJU 19 Float Percentage Of Total Shares Outstanding is 99.13% as of Aug. 05, 2026. GuruFocus rates STU:EJU with a GF Score™ of 19/100. The stock has 1 warning sign investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Aethlon Medical's float shares is 0.53 Mil. Aethlon Medical's total shares outstanding is 0.53 Mil. Aethlon Medical's float percentage of total shares outstanding is 99.13%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Aethlon Medical's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Aethlon Medical's Institutional Ownership is 0.94%.

STU:EJU
19GF Score
Aethlon Medical Inc STU:EJU
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aethlon Medical Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Aethlon Medical's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.53/0.53
=99.13%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 99.13% mean?
Aethlon Medical (STU:EJU) has a Float Percentage Of Total Shares Outstanding of 99.13% as of Aug. 05, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Aethlon Medical and its competitors.
Is Aethlon Medical's Float Percentage Of Total Shares Outstanding too high?
Aethlon Medical's current Float Percentage Of Total Shares Outstanding is 99.13%. Overall, Aethlon Medical has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Aethlon Medical's Float Percentage Of Total Shares Outstanding compare to NUMD and AMIX?
Aethlon Medical's Float Percentage Of Total Shares Outstanding of 99.13% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Aethlon Medical and its competitors. Aethlon Medical's current Float Percentage Of Total Shares Outstanding is 99.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aethlon Medical stock overvalued right now?
Aethlon Medical (STU:EJU) has a current Float Percentage Of Total Shares Outstanding of 99.13%. The current Float Percentage Of Total Shares Outstanding is 99.13%. Aethlon Medical's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Aethlon Medical (STU:EJU), the current Float Percentage Of Total Shares Outstanding is 99.13% as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aethlon Medical Business Description

Other Exchanges AEMD:USA
Address 11555 Sorrento Valley Road, Suite 203, San Diego, CA, USA, 92121
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
19GF Score

Get the complete analysis for STU:EJU

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€212.00
Price